Abstract
Iodine-124 positron emission tomography (PET) is a useful 3D imaging technique for diagnosis and management of thyroid diseases. The difficulty in interpretation of the PET scans with highly selective tracers, such as iodine-124, is the lack of identifiable anatomical structures, so an accurate anatomical localization of foci presenting abnormal uptake is problematic. Consequently, a combined PET/CT scanner can resolve these difficulties by co-registering PET and CT data in a single session allowing a correlation of functional and morphologic imaging. A case is presented where iodine-124 produced by a clinical cyclotron and FDG were used to acquire images with a combined PET/CT scanner for clinical staging. On the basis of the PET/CT exams the treatment of the patient was modified.
Similar content being viewed by others
References
Frilling A, Tecklenborg K, Görges R, Weber F, Clausen M, Broelsch EC (2001) Preoperative diagnostic value of fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma. Ann Surg 234:804–811
Frilling A, Görges R, Tecklenborg K, Gassmann P, Bockhorn M, Clausen M, Broelsch CE (2000) Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery 128:1067–1074
Alnafisi NS, Driedger AA, Coates G, Moote DJ, Raphael SJ (2000) FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma. J Nucl Med 41:1010–1015
Bakheet SM, Powe JE, Hammami MM, Ahmed M (1997) Comparison of F-18 FDG to I-123 and I-131 scans in thyroid carcinoma. Clin Nucl Med 22:438–439
Chung JK, So Y, Lee JS, Choi CW, Lim SM, Lee DS, Hong SW, Youn YK, Lee MC, Cho BY (1999) Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. J Nucl Med 40:986–992
Grunwald F, Kalicke T, Feine U, Lietzenmayer R, Scheidhauer K, Dietlein M, Schober O, Lerch H, Brandt-Mainz K, Burchert W, Hiltermann G, Cremerius U, Biersack HJ (1999) Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 26:1547–1552
Helal BO, Merlet P, Toubert ME, Franc B, Schvartz C, Gauthier-Koelesnikov H, Prigent A, Syrota A (2001) Clinical impact of FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative scanning results after therapy. J Nucl Med 42:1464–1469
Hooft L, Hoekstra OS, Deville W, Lips P, Teule GJ, Boers M, van Tulder MW (2001) Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer. J Clin Endocrinol Metab 86:3779–3786
Mechanick JI, Kim CK, Krynyckyi BR, Machac J, Urken ML (2000) Multiple papillary thyroid carcinoma metastases revealed on position emission tomography scan in a patient with negative 131I scan. Thyroid 10:929–930
van Tol KM, Jager PL, Dullaart RP, Links TP (2000) Follow-up in patients with differentiated thyroid carcinoma with positive 18F-fluoro-2-deoxy-D-glucose-positron emission tomography results, elevated thyroglobulin levels, and negative high-dose 131I posttreatment whole body scans. J Clin Endocrinol Metab 85:2082–2083
Wang W, Larson SM, Fazzari M, Tickoo SK, Kolbert K, Sgouros G, Yeung H, Macapinlac H, Rosai J, Robbins RJ (2000) Prognostic value of fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 85:1107–1113
Lambrecht RM, Woodhouse N, Phillips R, Wolczak D, Qureshi A, Reyes ED, Graser C, Al-Yanbawi S, Al-Rabiah A, Meyer W et al. (1988) Investigational study of iodine-124 with a positron camera. Am J Physiol Imaging 3:197–200
Crawford DC, Flower MA, Pratt BE, Hill C, Zweit J, McCready VR, Harmer CL (1997) Thyroid volume measurement in thyrotoxic patients: comparison between ultrasonography and iodine-124 positron emission tomography. Eur J Nucl Med 24:1470–1478
Erdi YE, Macapinlac H, Larson SM, Erdi AK, Yeung H, Furhang EE, Humm JL (1999) Radiation dose assessment for I-131 therapy of thyroid cancer using I-124 PET imaging. Clin Pos Imaging 2:41–46
Flower MA, al-Saadi A, Harmer CL, McCready VR, Ott RJ (1994) Dose-response study on thyrotoxic patients undergoing positron emission tomography. Eur J Nucl Med 21:531–536
Frey P, Townsend D, Flattet A, De Gautard R, Widgren S, Jeavons A, Christin A, Smith A, Long A, Donath A (1986) Tomographic imaging of the human thyroid using 124I. J Clin Endocrinol Metab 63:918–927
Frey P, Townsend D, Jeavons A, Donath A (1985) In vivo-imaging of the human thyroid with a positron camera using 124I. Eur J Nucl Med 10:472–476
Pentlow KS, Graham MC, Lambrecht RM, Daghighian F, Bacharach SL, Bendriem B, Finn RD, Jordan K, Kalaigian H, Karp JS, Robeson WR, Larson SM (1996) Quantitative imaging of iodine-124 with PET. J Nucl Med 37:1557–1562
Eschmann SM, Reischl G, Bilger K, Kupferschlager J, Thelen MH, Dohmen BM, Besenfelder H, Bares R (2002) Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET. Eur J Nucl Med 29:760–767
Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, Jerin J, Young J, Byars L, Nutt R (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41:1369–1379
Townsend DW, Cherry SR (2001) Combined anatomy and function: the path of true image fusion. Eur Radiol 11:1968–1974
Maxon HR (1999) Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer. Q J Nucl Med 43:313–323
Maxon HR, Thomas SR, Samaratunga RC (1997) Dosimetric considerations in the radioiodine treatment of macrometastases and micrometastases from differentiated thyroid cancer. Thyroid 7:183–187
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Freudenberg, L.S., Antoch, G., Görges, R. et al. Combined PET/CT with iodine-124 in diagnosis of spread metastatic thyroid carcinoma: a case report. Eur Radiol 13 (Suppl 6), L19–L23 (2003). https://doi.org/10.1007/s00330-003-1884-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-003-1884-x